SCM
TECX

Superstring Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Superstring Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-119,286
Closed -$1.87M – 63
2025
Q3 		$1.87M Buy
119,286
+40,228
+51% +$830K 1.84% 22
2025
Q2 		$1.57M Buy
79,058
+28,312
+56% +$574K 1.86% 19
2025
Q1 		$899K Buy
+50,746
New +$1.65M 1.07% 23

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Superstring Capital Management's TECX Position: Q4 2025 in Review

Superstring Capital Management sold out of Tectonic Therapeutic (TECX) in Q4 2025, closing a stake of 119,286 shares — an estimated $1.87M sold.

Superstring Capital Management first reported a position in TECX in Q1 2025 and held it in 3 quarters. The position peaked at $1.87M in Q3 2025. 105 funds tracked by Wall St. Rank hold TECX as of Q4 2025.

  • Superstring Capital Management reported no remaining Tectonic Therapeutic position as of Q4 2025 after selling out during the quarter.
  • Superstring Capital Management sold 119,286 Tectonic Therapeutic shares in Q4 2025, an estimated $1.87M.
  • Superstring Capital Management first reported a position in Tectonic Therapeutic in Q1 2025 and held it in 3 quarters.
  • Superstring Capital Management's Tectonic Therapeutic position peaked at $1.87M in Q3 2025.
  • 105 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2025.

Based on Superstring Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.